Breakfast BriefPublished on: 30 Sept 2019
ESMO 2019: NSCLC – "We now have many frontline treatment options to discuss with patients"
Prof. Solange Peters, MD, PhD, CHUV Lausanne, puts the research she presented at ESMO 2019 in perspective by explaining the complex CheckMate 227 trial and giving an update on the NICOLAS trial.